Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis (NCT04024917) | Clinical Trial Compass
RecruitingNot Applicable
Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
France60 participantsStarted 2021-09-21
Plain-language summary
The investigator proposes to use the cardiac coherence technique to diminish anxiety before the surgery of a peritoneal carcinosis of colon or stomach or ovary and pseudomyxoma or peritoneal mesothelioma.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age over 18 years
✓. Patients with peritoneal carcinosis awaiting cytoreductive surgery
✓. Patients who scored strictly above 3 on the visual analogue anxiety scale and/or the psychological distress scale
✓. Patients with sufficient command of the French language
✓. Patient affiliated to a French social security system
✓. Patient hospitalized at the Institute of cancer of Montpellier the day before his cytoreductive surgery (at T1 = D-1)
✓. Signing of informed consent before any specific trial procedure
Exclusion criteria
✕. Patients who already have daily practice of cardiac coherence
✕. Presence of proven psychiatric disorders (e.g., mental retardation, psychotic disorders, learning disabilities, attention deficit/hyperactivity, bipolar disorder, etc.) other than mood disorders that are reactive to the disease experience, or receiving psychotic treatment that may impair thinking, judgment or discernment
✕. Physical or sensory inability to respond to questionnaires
✕. Patients who have had a heart transplant or bypass surgery in the Year before surgery
✕. Patient with a history of uncontrolled neurological pathology within the last 6 months before inclusion in the trial
What they're measuring
1
Cardiac Coherence Program Adherence Rate
Timeframe: Around 10 days
Trial details
NCT IDNCT04024917
SponsorInstitut du Cancer de Montpellier - Val d'Aurelle